On the Imaging Modalities for Lung Cancer Screening: Low-Dose CT Scan Could Lead to a Significant Reduction of Mortality Rates of the Patient
Abstract
The NLST- (USA, 2011) [1] and NELSON- (Dutch-Belgian, 2009- 2017) [2,3] randomized control trials on low-dose-CT scans for lung cancer (LDCT) screening have reported a statistically significant reduction of mortality rates of the patient with lung cancers; and the LDCT scan has become an international standard test for screening, being expected to effectively detect curable lung cancers.